From Bench to Bedside – BreastDefense and Translational Medicine

Translational research is generally considered a process that starts in the lab–the “bench”–where a new drug, device, or procedure is developed, and ends with the production that makes it available in the clinic–the “bedside.” Barry S. Coller from the Rockefeller University, NY defines translational medicine as: “The application of the scientific method to address a…

Read More

Many Women Could Be Spared Chemotherapy

  The largest precision medicine study ever done was presented at a plenary session at the annual meeting of the American Society of Clinical Oncology in Chicago. Researchers looked at more than 10,000 women aged 18-75. Researchers were looking at whether the standard of care of chemotherapy and endocrine therapy benefit all women with the…

Read More

What do Dogs and BreastDefense have in Common?

Some biologists think that a target of 99% accuracy for any cancer screen is unattainable. It seems that SignPost is not alone in this pursuit. According to a company called BioScent Dx, dogs are able to smell minute changes in a human bio-markers including hormones, proteins and other organic compounds. This has lead to dogs…

Read More

The Sharks and The Minnows

The wide net of cancer detection is picking up the Sharks – the aggressive tumors – and the Minnows- the non-aggressive tumors. “We are not seeing enough of the really lethal cancers, and we’re finding too many of the slow moving ones that probably don’t need to be found” says Laura Esserman, a breast cancer…

Read More